SCHEMBL506356

SCHEMBL506356

CCCCCC=CCCCCC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.68
TRPV1 Q8NER1 2/20 0.68
TERT O14746 3/20 0.56
PTPN1 P18031 3/20 0.56
PPARG P37231 3/20 0.56
PPARD Q03181 3/20 0.56
PPARA Q07869 3/20 0.56
CYP1A2 P05177 2/20 0.56
MAPT P10636 2/20 0.56
CYP2C19 P33261 2/20 0.56
BLM P54132 2/20 0.56
HSD17B10 Q99714 2/20 0.56
FABP4 P15090 2/20 0.56
KMT2A Q03164 2/20 0.56
GMNN O75496 1/20 0.56
USP2 O75604 1/20 0.56
LMNA P02545 1/20 0.56
POLB P06746 1/20 0.56
CYP2C9 P11712 1/20 0.56
ALOX15 P16050 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1324284 1.00 FAAH (0.68) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL819092 1.00 FAAH (0.68) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL29274398 1.00 FAAH (0.68) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL22654036 0.96 FAAH (0.74) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL24218814 0.96 FAAH (0.74) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL23291808 0.96 FAAH (0.74) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL23040321 0.96 FAAH (0.74) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL22501120 0.96 FAAH (0.74) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL21942430 0.96 FAAH (0.74) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL22654037 0.96 FAAH (0.74) FAAHTRPV1TERTPTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 903 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260130860-A1 LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS FLAGSHIP LABS 114, INC. (US) 2026-05-14 US claimed
EP-4687854-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY Flagship Labs 114, Inc. (US) 2026-02-11 EP claimed
WO-2024211865-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY OMEGA THERAPEUTICS, INC. (US) 2024-10-10 WO claimed
US-12025877-B2 Display panel and manufacturing method thereof TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) 2024-07-02 US claimed
WO-2024073678-A2 PHOSPHOLIPIDS CONTAINING A HETEROCYCLE RING HAVING A TERTIARY AMINE OR AMIDE OMEGA THERAPEUTICS, INC. (US) 2024-04-04 WO claimed
US-11930698-B2 Tetradentate platinum and palladium complex emitters containing phenyl-pyrazole and its analogues ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2024-03-12 US claimed
US-20240045260-A1 DISPLAY PANEL AND MANUFACTURING METHOD THEREOF TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) 2024-02-08 US claimed
WO-2023225621-A2 LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS OMEGA THERAPEUTICS, INC. (US) 2023-11-23 WO claimed
CN-115932248-A Single-molecule immunoassay method based on aggregation-induced emission material 苏州宇测生物科技有限公司 2023-04-07 CN claimed
CN-115897250-A Hydrophobic photochromic cotton knitted fabric and preparation method thereof 西安工程大学 2023-04-04 CN claimed
US-4855519-A Method for producing arylethylene NIPPON PETROCHEMICALS COMPANY (JP) 1989-08-08 US claimed
EP-0316014-A2 Method for producing arylethylenes NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) 1989-05-17 EP claimed
US-4802058-A DISTILLATION, DEHYDROGENATION, DISTILLATION, AND HYDROGENATION NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) 1989-01-31 US claimed
EP-0282013-A2 Novel method for refining electrical insulating oil NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) 1988-09-14 EP claimed
US-4423275-A Olefin conversion ETHYL CORPORATION (US) 1983-12-27 US claimed
US-4291187-A USING A RHENIUM OR TUNGSTEN CARBENE CATALYST COMPLEX PHILLIPS PETROLEUM COMPANY (US) 1981-09-22 US claimed
US-4225588-A POLYCYCLIC NITROGEN-CONTAINING COMPOUNDS AS POTENTIATORS FOR BLEOMYCINS OR PHLEOMYCINS COMMONWEALTH SCIENTIFIC & INDUSTRIAL RESEARCH ORGANIZATION (AU) 1980-09-30 US claimed
US-4115464-A DEHYDROGENATION, METAL PHOSPHATE CATALYST THE STANDARD OIL COMPANY (US) 1978-09-19 US claimed
US-4061772-A HYPOURICEMIC, URICOSURIC, HYPOLIPIDEMIC HOECHST AKTIENGESELLSCHAFT (DT) 1977-12-06 US claimed
US-4001431-A DERIVATIVES OF THE 1,2-DIARYLETHYLENE- AND PHARMACEUTICAL COMPOSITIONS THEREOF HOECHST AKTIENGESELLSCHAFT (DT) 1977-01-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260130860-A1 LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS NSUN3, NSUN2, LDLR FAAH 3270/4885TRPV1 3541/4885TERT 2186/4885
US-11930698-B2 Tetradentate platinum and palladium complex emitters containing phenyl-pyrazole and its analogues PDCD1, PDCD11, TYMP FAAH 4614/4885TRPV1 3411/4885TERT 173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.